Last minute! Norwegian health officials announced that the deliveries of the coronavirus vaccine developed by BioNTech and the US pharmaceutical company Pfizer will decrease to Norway and Europe. It was stated that the company will increase its production capacity.
Norwegian health officials announced that the deliveries of the coronavirus vaccine developed by BioNTech and the US pharmaceutical company Pfizer will be reduced to Norway and Europe. It was stated that the company will increase its production capacity.
The Norwegian Public Health Administration (FHI) announced that the coronavirus vaccine developed by BioNTech and the US pharmaceutical company Pfizer will decrease and delay deliveries across Europe and Norway. FHI stated that deliveries to Norway will decrease by 18 percent. In the statement made by FHI, it was stated that “The decrease in question will also affect European countries. It is not yet clear how long it will take Pfizer to increase its production capacity from 1.3 to 2 billion doses per year.” FHI Infectious Disease Prevention Specialist Geir Bukholm announced today that FHI has been informed of the change.
The latest developments regarding the vaccine, which is thought to bring hope to the world, raise questions in everyone’s minds. What is the latest situation regarding vaccination? What are the side effects of the vaccine, is it fatal? These are what everyone is curious about.
Comments are closed.